-
Mashup Score: 2Ponatinib Is Associated With Improved Survival in Ph+ ALL With MRD Positivity After Induction - 3 day(s) ago
A post hoc analysis of the PhALLCON showed response and survival benefits with imatinib in Ph-positive ALL with MRD negativity after induction.
Source: www.onclive.comCategories: General Medicine NewsTweet
Ponatinib Is Associated With Improved Survival in Ph+ #ALL With MRD Positivity After Induction @EHA_Hematology #EHA25 #oncology https://t.co/aCLuAnFNk9